Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Alaunos Therapeutics, Inc.

TCRT · Nasdaq · CIK 0001107421 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

15 Form 4 transaction lines observed in the same window
0 sales · 15 option, withholding, award, gift or other lines

Last qualifying purchase2022-11-29 · Postma Robert W · $487.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Weis HolgerChief Executive Officer
○○○○○○
Vieser JaimeDirector
○○○
Postma Robert WDirector
○○○
Jerman Michael AllenDirector
○○○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-11-29 · Postma Robert W.

Recent Form 4 activity

0Purchases
0Sales
21Other Form 4 lines
21SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER15 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
9,736
Previous report
6,075
Avg daily volume
4,314,053
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-11-29Vieser JaimePurchase (P)Common Stock1,250,000USD 0.65USD 812,500SEC filing ↗
2022-11-29Postma Robert WPurchase (P)Common Stock750,000USD 0.65USD 487,500SEC filing ↗
2021-11-17Boyle Kevin S. Sr.Purchase (P)Common Stock9,116USD 1.40USD 12,762SEC filing ↗
2021-11-16Boyle Kevin S. Sr.Purchase (P)Common Stock884USD 1.40USD 1,238SEC filing ↗
2021-09-29Vieser JaimePurchase (P)Common Stock100,000USD 1.91USD 191,000SEC filing ↗
2021-09-02Postma Robert WPurchase (P)Common Stock75,000USD 1.73USD 129,750SEC filing ↗
2021-09-02Hagen HeidiPurchase (P)Common Stock23,770USD 1.76USD 41,835SEC filing ↗
2021-09-01Weis HolgerPurchase (P)Common Stock50,000USD 1.83USD 91,500SEC filing ↗
2021-09-01Huang JamesPurchase (P)Common Stock100,000USD 1.71USD 171,000SEC filing ↗

Form 4 evidence

21 transaction lines in the latest 365-day window; 81 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-06Weis HolgerAward / grant (A)Common Stock23,564USD 0.74USD 17,541SEC filing ↗
2026-10-06Vieser JaimeAward / grant (A)Common Stock22,669USD 0.74USD 16,875SEC filing ↗
2026-10-06Postma Robert WAward / grant (A)Common Stock21,829USD 0.74USD 16,250SEC filing ↗
Show recent Form 4 evidence (21 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-06Weis HolgerAward / grant (A)Common Stock23,564USD 0.74USD 17,541SEC filing ↗
2026-10-06Vieser JaimeAward / grant (A)Common Stock22,669USD 0.74USD 16,875SEC filing ↗
2026-10-06Postma Robert WAward / grant (A)Common Stock21,829USD 0.74USD 16,250SEC filing ↗
2026-10-06Jerman Michael AllenAward / grant (A)Common Stock20,990USD 0.74USD 15,625SEC filing ↗
2026-08-06Weis HolgerAward / grant (A)Common Stock4,363USD 2.01USD 8,770SEC filing ↗
2026-07-23Weis HolgerAward / grant (A)Common Stock4,568USD 1.92USD 8,771SEC filing ↗
2026-07-23Vieser JaimeAward / grant (A)Common Stock8,789USD 1.92USD 16,875SEC filing ↗
2026-07-23Postma Robert WAward / grant (A)Common Stock8,463USD 1.92USD 16,249SEC filing ↗
2026-07-23Jerman Michael AllenAward / grant (A)Common Stock8,138USD 1.92USD 15,625SEC filing ↗
2026-06-30Weis HolgerAward / grant (A)Common Stock3,880USD 2.26USD 8,769SEC filing ↗
2026-06-12Weis HolgerAward / grant (A)Common Stock7,761USD 2.26USD 17,540SEC filing ↗
2026-05-22Weis HolgerAward / grant (A)Common Stock3,700USD 2.37USD 8,769SEC filing ↗
2026-04-29Vieser JaimeAward / grant (A)Common Stock6,515USD 2.59USD 16,874SEC filing ↗
2026-04-29Postma Robert WAward / grant (A)Common Stock6,274USD 2.59USD 16,250SEC filing ↗
2026-04-29Jerman Michael AllenAward / grant (A)Common Stock6,032USD 2.59USD 15,623SEC filing ↗
2026-01-12Vieser JaimeAward / grant (A)Common Stock5,839USD 2.89USD 16,875SEC filing ↗
2026-01-12Postma Robert WAward / grant (A)Common Stock5,622USD 2.89USD 16,248SEC filing ↗
2026-01-12Jerman Michael AllenAward / grant (A)Common Stock5,406USD 2.89USD 15,623SEC filing ↗
2025-11-21Vieser JaimeAward / grant (A)Common Stock5,340USD 3.16USD 16,874SEC filing ↗
2025-11-21Postma Robert WAward / grant (A)Common Stock5,142USD 3.16USD 16,249SEC filing ↗
2025-11-21Jerman Michael AllenAward / grant (A)Common Stock4,183USD 3.16USD 13,218SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTCRT
CIK0001107421
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history81 transaction lines from 2020-01-02 to 2026-10-06
10 P purchase lines · 14 S sale lines · 57 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.